PSK-Health Takes the Global Stage: Showcasing Innovation at MEDICA 2025
Recently, the International Medical Equipment Exhibition (MEDICA) was held in Düsseldorf, Germany. Chongqing PSK-Health Sci-tech Development Co., Ltd. participated in the exhibition and showcased its core product – External Counter Pulsation (EECP) therapy equipment.
As a pivotal platform in the global medical device sector, MEDICA gathers exhibitors and professional audiences from around the world.
During the exhibition, the booth of Chongqing PSK attracted a large number of visitors. The company’s staff introduced the functions and characteristics of the EECP equipment to customers and professionals from various countries, and conducted on-site operational demonstrations.
According to the person in charge of the company’s exhibition team, this marks their second participation in MEDICA since last year. In recent years, the global awareness and acceptance of EECP technology have been gradually increasing. By leveraging this international platform, the company has not only demonstrated its product strength but also gained insights into industry trends, as well as the market demands and regulatory differences across various regions.
According to the person in charge of the company’s exhibition team, this marks their second participation in MEDICA since last year. In recent years, the global awareness and acceptance of EECP technology have been gradually on the rise. By leveraging this international platform, the company has not only demonstrated its product strength but also gained insights into industry trends, enabling it to better understand the market demands and regulatory differences across various regions.
It is reported that during the four-day exhibition, Chongqing PSK conducted extensive interactions and communications with medical device distributors, representatives of medical institutions, and other parties from Europe, Asia, Africa, and other regions, and initially reached several cooperation intentions. This participation has accumulated valuable resources for the company to further deepen its international market layout.
About Chongqing Pushikang:
Chongqing PSK-Health Sci-tech Development Co., Ltd. is an enterprise specializing in the R&D, production, and sales of medical devices. Its main products include External Counter Pulsation (EECP) therapy equipment, as well as rehabilitation devices such as the Six-Minute Walk Test (6MWT) rehabilitation system and upper/lower limb rehabilitation trainers.
During the MEDICA trade fair, Chongqing PSK-Health Sci-tech Development Co., Ltd. also participated in the “China (Chongqing) – Germany (Düsseldorf) Healthcare Industry Cooperation Exchange Conference”, co-hosted by the Chongqing Municipal Commission of Commerce, the Chongqing Municipal Commission of Economy and Information Technology, and the People’s Government of Bishan District, Chongqing.
Attended by approximately 50 participants, including government representatives, healthcare enterprise delegates, and chamber of commerce representatives, the conference aimed to help European enterprises gain an in-depth understanding of Chongqing’s broad market prospects, industrial policies, and manufacturing advantages.
As a professional manufacturer of EECP (Enhanced External Counterpulsation) therapy equipment in Chongqing and even China, Chongqing PSK-Health emerged as one of the focal points at the conference.
Company representatives systematically introduced PSK-Health’s core strengths in EECP equipment R&D, manufacturing, and clinical application to the attendees, and shared the remarkable efficacy and clinical data of its products in treating diseases such as ischemic heart disease and heart failure. Representatives of PSK-Health stated that relying on Chongqing’s solid manufacturing foundation and proactive industrial policies, the enterprise has established a complete system covering R&D, production, and global services. Its products integrate innovative technologies such as intelligent control and precise pressure regulation, dedicated to providing safe and efficient non-invasive circulatory therapy solutions for patients worldwide.